Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure

Name: Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure
License: Public Domain

Assistance Publique - Hôpitaux de Paris

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hcc - hepatocellular carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 373582
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.